BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16569609)

  • 1. Prediction of peptide binding to major histocompatibility complex class II molecules through use of boosted fuzzy classifier with SWEEP operator method.
    Takahashi H; Honda H
    J Biosci Bioeng; 2006 Feb; 101(2):137-41. PubMed ID: 16569609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Class II HLA-peptide binding prediction using structural principles.
    Mohanapriya A; Lulu S; Kayathri R; Kangueane P
    Hum Immunol; 2009 Mar; 70(3):159-69. PubMed ID: 19187794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based design and evaluation of MHC class II binding peptides.
    de Haan EC; Wauben MH; Grosfeld-Stulemeyer MC; Moret EE
    Biologicals; 2001; 29(3-4):289-92. PubMed ID: 11851330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative prediction of MHC-II binding affinity using particle swarm optimization.
    Zhang W; Liu J; Niu Y
    Artif Intell Med; 2010 Oct; 50(2):127-32. PubMed ID: 20541921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of human major histocompatibility complex class II binding peptides by continuous kernel discrimination method.
    He J; Yang G; Rao H; Li Z; Ding X; Chen Y
    Artif Intell Med; 2012 Jun; 55(2):107-15. PubMed ID: 22134095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward prediction of class II mouse major histocompatibility complex peptide binding affinity: in silico bioinformatic evaluation using partial least squares, a robust multivariate statistical technique.
    Hattotuwagama CK; Toseland CP; Guan P; Taylor DJ; Hemsley SL; Doytchinova IA; Flower DR
    J Chem Inf Model; 2006; 46(3):1491-502. PubMed ID: 16711768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting peptides bound to I-Ag7 class II histocompatibility molecules using a novel expectation-maximization alignment algorithm.
    Chang KY; Suri A; Unanue ER
    Proteomics; 2007 Feb; 7(3):367-77. PubMed ID: 17211830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ab initio prediction of peptide-MHC binding geometry for diverse class I MHC allotypes.
    Bordner AJ; Abagyan R
    Proteins; 2006 May; 63(3):512-26. PubMed ID: 16470819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A motif detection and classification method for peptide sequences using genetic programming.
    Tomita Y; Kato R; Okochi M; Honda H
    J Biosci Bioeng; 2008 Aug; 106(2):154-61. PubMed ID: 18804058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BiodMHC: an online server for the prediction of MHC class II-peptide binding affinity.
    Wang L; Pan D; Hu X; Xiao J; Gao Y; Zhang H; Zhang Y; Liu J; Zhu S
    J Genet Genomics; 2009 May; 36(5):289-96. PubMed ID: 19447377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flexibility of the MHC class II peptide binding cleft in the bound, partially filled, and empty states: a molecular dynamics simulation study.
    Yaneva R; Springer S; Zacharias M
    Biopolymers; 2009 Jan; 91(1):14-27. PubMed ID: 18767126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A practical guide to structure-based prediction of MHC-binding peptides.
    Ranganathan S; Tong JC
    Methods Mol Biol; 2007; 409():301-8. PubMed ID: 18450010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Bayesian regression approach to the prediction of MHC-II binding affinity.
    Zhang W; Liu J; Niu YQ; Wang L; Hu X
    Comput Methods Programs Biomed; 2008 Oct; 92(1):1-7. PubMed ID: 18562039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonlinear predictive modeling of MHC class II-peptide binding using Bayesian neural networks.
    Winkler DA; Burden FR
    Methods Mol Biol; 2007; 409():365-77. PubMed ID: 18450015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of MHC class II binders using the ant colony search strategy.
    Karpenko O; Shi J; Dai Y
    Artif Intell Med; 2005; 35(1-2):147-56. PubMed ID: 16061368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. POPI: predicting immunogenicity of MHC class I binding peptides by mining informative physicochemical properties.
    Tung CW; Ho SY
    Bioinformatics; 2007 Apr; 23(8):942-9. PubMed ID: 17384427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-binding motifs for the I-Ad MHC class II molecule: alternate pH-dependent binding behavior.
    Chaves FA; Richards KA; Torelli A; Wedekind J; Sant AJ
    Biochemistry; 2006 May; 45(20):6426-33. PubMed ID: 16700553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive Bayesian neural network models of MHC class II peptide binding.
    Burden FR; Winkler DA
    J Mol Graph Model; 2005 Jun; 23(6):481-9. PubMed ID: 15878832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noble metals strip peptides from class II MHC proteins.
    De Wall SL; Painter C; Stone JD; Bandaranayake R; Wiley DC; Mitchison TJ; Stern LJ; DeDecker BS
    Nat Chem Biol; 2006 Apr; 2(4):197-201. PubMed ID: 16505807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of intramural metastases and lymph node metastases of esophageal cancer from gene expression based on boosting and projective adaptive resonance theory.
    Takahashi H; Aoyagi K; Nakanishi Y; Sasaki H; Yoshida T; Honda H
    J Biosci Bioeng; 2006 Jul; 102(1):46-52. PubMed ID: 16952836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.